Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase 1, double-blind, placebo-controlled study evaluating single subcutaneous administrations of a human interleukin-12/23 monoclonal antibody in subjects with plaque psoriasis.
Gottlieb AB, Cooper KD, McCormick TS, Toichi E, Everitt DE, Frederick B, Zhu Y, Pendley CE, Graham MA, Mascelli MA. Gottlieb AB, et al. Among authors: frederick b. Curr Med Res Opin. 2007 May;23(5):1081-92. doi: 10.1185/030079907x182112. Curr Med Res Opin. 2007. PMID: 17519075 Clinical Trial.
A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis.
Kauffman CL, Aria N, Toichi E, McCormick TS, Cooper KD, Gottlieb AB, Everitt DE, Frederick B, Zhu Y, Graham MA, Pendley CE, Mascelli MA. Kauffman CL, et al. Among authors: frederick b. J Invest Dermatol. 2004 Dec;123(6):1037-44. doi: 10.1111/j.0022-202X.2004.23448.x. J Invest Dermatol. 2004. PMID: 15610511 Free article. Clinical Trial.
199 results